Brief: Phio Pharmaceuticals Announces Dosing Of First Patient In Collaborative Clinical Trial With Agonox And Providence Cancer Institute
21/08/2023 12:32
Aug 21 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS ANNOUNCES DOSING OF FIRST PATIENT IN
COLLABORATIVE CLINICAL TRIAL WITH AGONOX, INC. AND PROVIDENCE
CANCER INSTITUTE
Source text for Eikon: ID:nGNXbZWXZY
Further company coverage: PHIO.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing